Key points
- RoboStrategy trades on the Nasdaq as BOT. The company itself is a closed-end fund, not an operating business, holding private equity stakes in robotics and embodied AI startups, including Figure AI and Apptronik.
- The fund's net assets were $248.9 million as of June 30, 2026. It just registered the resale of up to 14.1 million shares tied to a deal letting it sell up to $2 billion in new stock to Roth Principal Investments, about eight times the fund's current size.
- Any shares sold under the facility must price at or above the fund's net asset value per share, a built-in guardrail, but the prospectus itself warns the deal "could result in substantial dilution" to existing shareholders.
- Standard Bots is the fund's largest holding at 35% of net assets, followed by Figure AI and Dyna at 15% each, with smaller stakes in Apptronik, Dexmate, Path Robotics and eight other startups.
There is a ticker on the Nasdaq that lets ordinary investors buy a piece of some of the hottest names in humanoid robotics before they ever go public. It's called RoboStrategy, ticker BOT, and it started trading May 11, 2026. Two months later, it just filed paperwork registering shares tied to a deal letting it sell up to $2 billion worth of new stock over time, more than eight times the size of the entire fund today. We've had BOT on our own tracked ticker list and SEC filings feed for a while, which is how this filing crossed our radar.
What RoboStrategy actually is
RoboStrategy, Inc. is a closed-end fund, registered under the Investment Company Act of 1940, built to buy equity stakes in private, venture-backed robotics and "embodied AI" companies, the kind of startups normally off-limits to anyone without venture capital connections of their own. The fund's adviser is FP Strategies LLC, doing business as RoboStrategy Advisors, based in San Juan, Puerto Rico, which charges an annual management fee of 2.5% of the fund's average gross assets.
You buy shares of BOT on the Nasdaq like any other stock. In exchange, you get indirect exposure to a basket of private robotics startups that RoboStrategy has already invested in, no venture capital connections or accreditation minimums required.
What is actually inside the fund
As of June 30, 2026, RoboStrategy held stakes in 14 companies worth a combined $248.9 million. The portfolio is heavily concentrated in a handful of names:
- Standard Bots, an industrial robotics maker, is the biggest single bet in the portfolio: 35% of net assets, about $87 million.
- Figure AI is next at 15%, about $37.25 million, held indirectly through a limited partnership interest in a special purpose vehicle rather than a direct stake. It's the humanoid robot company founded by Brett Adcock, who also started Archer Aviation (NYSE: ACHR).
- Dyna, Inc., a general-purpose robotics company, matches that 15%, also around $37.25 million.
- Apptronik, another humanoid robotics maker, is split across two separate positions that together run roughly 15%.
- Dexmate accounts for about 10% across two more positions. The remaining nine companies, Path Robotics, Eccentric Machines, REK, GMI Computing, Cyan Robotics, Nox Metals, Endiatx, Allonic and Purple Rhombus, are smaller positions.
Notably, some of the Apptronik and Figure AI stakes were contributed to the fund in kind, before it registered under the 1940 Act, by entities controlled by Marc Weinstein and Andrew Kang, who appear to be among the fund's founders or early insiders.
The $2 billion catch
The filing that prompted this piece is a prospectus registering the resale of up to 14.1 million shares of RoboStrategy stock by Roth Principal Investments, an affiliate of the broker-dealer Roth Capital Partners. The shares stem from a Common Stock Purchase Agreement RoboStrategy signed with Roth Principal Investments on the same day it went public, in which Roth committed to buy, at RoboStrategy's own discretion and over time, up to $2,000,000,000 worth of RoboStrategy stock.
That is not a typo. A fund with $248.9 million in net assets has lined up the ability to sell roughly eight times its own size in new shares, whenever it chooses, over the life of the agreement.
Here is the mechanism: RoboStrategy issues new shares to Roth Principal Investments, who resells them on the open market through Roth Capital Partners. RoboStrategy itself never sells directly to the public. Because Roth's own affiliate broker stands to profit from executing those resales, the deal counts as a conflict of interest under FINRA rules, which is why the prospectus had to bring in a separate "qualified independent underwriter," Digital Offering, LLC, to review the offering.
Why the price floor does not fully protect you
There is a real guardrail built into this deal. Any shares RoboStrategy sells to Roth Principal Investments have to price at or above the higher of a contractual floor or the fund's net asset value per share at the time of the sale. That matters because closed-end funds are generally barred from selling stock below net asset value, which stops the fund from directly destroying value per share with each draw.
What it does not stop is dilution of ownership. Every new share sold under the facility increases the total share count, which shrinks the percentage of the fund every existing shareholder owns, even if the price per share does not fall below net asset value. The prospectus says this plainly: "sales to Roth Principal Investments by us could result in substantial dilution to the interests of other holders of our common stock." It also warns that a large volume of new shares hitting the market, or the anticipation of it, can weigh on the stock price on its own.
Not the only way in
Investors have found other workarounds for buying into private robotics companies too. Agility Robotics, another humanoid robot maker, is going public the traditional SPAC route through Churchill Capital Corp XI, ticker CCXI, a structure we broke down in our explainer on how SPACs work and again in our deep dive on the Agility Robotics deal. A SPAC merger and a closed-end fund like RoboStrategy solve the same basic problem, public access to a private company, in very different ways, with different risks attached to each.
The bottom line
RoboStrategy is a real way to own a slice of Figure AI, Apptronik and a dozen other private robotics companies without needing venture capital access. But the fund is barely two months old and has already lined up the ability to multiply its share count many times over. That doesn't make BOT a bad investment on its own, funds like this often need fresh capital to keep buying into new portfolio companies as opportunities come up, but it's a meaningful overhang worth watching before assuming today's net asset value is a stable floor.
Sources
Figures are from RoboStrategy's SEC filings as described above. This is general information about a fund's structure and a specific filing, not investment advice.
